Mirvetuximab-MMAE

Mirvetuximab-MMAE is an ADC targeting FOLR1 (folate receptor 1). It can be used in ovarian and other FRα-positive cancer research. MW :145.96 KD.

Mirvetuximab-MMAE

CAS No.

Purity & Quality Control

≥99

Biological Activity

Description Mirvetuximab-MMAE is an ADC targeting FOLR1 (folate receptor 1). It can be used in ovarian and other FRα-positive cancer research. MW :145.96 KD.

Product Details

Molecular Weight 145.96
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Mirvetuximab-MMAE | Mirvetuximab-MMAE supplier | purchase Mirvetuximab-MMAE | Mirvetuximab-MMAE cost | Mirvetuximab-MMAE manufacturer | order Mirvetuximab-MMAE | Mirvetuximab-MMAE distributor